These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 6420645
21. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux. Matsumoto T, Ono Y, Kurono M, Kuromiya A, Nakamura K, Bril V. J Pharmacol Sci; 2009 Feb; 109(2):203-10. PubMed ID: 19212096 [Abstract] [Full Text] [Related]
26. The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats. Sasaki H, Naka K, Kishi Y, Furuta M, Sanke T, Mukoyama M, Nanjo K. Exp Neurol; 1997 Aug; 146(2):466-70. PubMed ID: 9270057 [Abstract] [Full Text] [Related]
27. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes. Price DE, Airey CM, Alani SM, Wales JK. Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261 [Abstract] [Full Text] [Related]
28. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Naruse K, Kasuya Y, Mizubayashi R, Miwa K, Yasuda Y, Kamiya H, Ienaga K, Sakakibara F, Koh N, Hotta N. Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378 [Abstract] [Full Text] [Related]
29. Characterization of a novel aldose reductase inhibitor, TAT, and its effects on streptozotocin-induced diabetic neuropathy in rats. Inukai S, Agata M, Sato M, Naitou A, Matsukawa H, Goto M. Jpn J Pharmacol; 1993 Mar; 61(3):221-7. PubMed ID: 8483299 [Abstract] [Full Text] [Related]
30. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity. Hirata Y, Okada K. Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992 [Abstract] [Full Text] [Related]
31. Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes. Kanda M, Eto K, Tanabe N, Sugiyama A, Hashimoto K, Ueno A. Jpn J Pharmacol; 1997 Mar; 73(3):221-8. PubMed ID: 9127817 [Abstract] [Full Text] [Related]